Comprehensive Mapping of p53 Pathway Alterations Reveals an Apparent Role for Both SNP309 and MDM2 Amplification in Sarcomagenesis M Ito, L Barys, T O'Reilly, S Young, B Gorbatcheva, J Monahan, ... Clinical Cancer Research 17 (3), 416-426, 2011 | 132 | 2011 |
Low stromal Foxp3+ regulatory T-cell density is associated with complete response to neoadjuvant chemoradiotherapy in rectal cancer MJ McCoy, C Hemmings, TJ Miller, SJ Austin, MK Bulsara, N Zeps, ... British journal of cancer 113 (12), 1677-1686, 2015 | 79 | 2015 |
The elaboration of a critical framework for understanding cancer: the cancer stem cell hypothesis C Hemmings Pathology 42 (2), 105-112, 2010 | 47 | 2010 |
The unfolded protein response is activated in Helicobacter-induced gastric carcinogenesis in a non-cell autonomous manner M Baird, PW Ang, I Clark, D Bishop, M Oshima, MC Cook, C Hemmings, ... Laboratory investigation 93 (1), 112-122, 2013 | 44 | 2013 |
Tumour-infiltrating regulatory T cell density before neoadjuvant chemoradiotherapy for rectal cancer does not predict treatment response MJ McCoy, C Hemmings, CC Anyaegbu, SJ Austin, TF Lee-Pullen, ... Oncotarget 8 (12), 19803, 2017 | 41 | 2017 |
The prognostic value of cancer stem-like cell markers SOX2 and CD133 in stage III colon cancer is modified by expression of the immune-related markers FoxP3, PD-L1 and CD3 TJ Miller, MJ McCoy, C Hemmings, MK Bulsara, B Iacopetta, CF Platell Pathology 49 (7), 721-730, 2017 | 40 | 2017 |
Universal molecular screening does not effectively detect Lynch syndrome in clinical practice B Brennan, CT Hemmings, I Clark, D Yip, M Fadia, DR Taupin Therapeutic advances in gastroenterology 10 (4), 361-371, 2017 | 32 | 2017 |
Personalising pancreas cancer treatment: when tissue is the issue KM Sjoquist, VT Chin, LA Chantrill, C O’Connor, C Hemmings, DK Chang, ... World journal of gastroenterology: WJG 20 (24), 7849, 2014 | 31 | 2014 |
Is carcinoma a mesenchymal disease? The role of the stromal microenvironment in carcinogenesis C Hemmings Pathology-Journal of the RCPA 45 (4), 371-381, 2013 | 29 | 2013 |
Neoadjuvant chemoradiotherapy for rectal cancer: how important is tumour regression? MJ McCoy, C Hemmings, S Hillery, C Penter, MK Bulsara, N Zeps, ... ANZ journal of surgery 87 (12), E233-E239, 2017 | 25 | 2017 |
Thyroid pathology in four patients with Cowden's disease CT Hemmings Pathology 35 (4), 311-314, 2003 | 25 | 2003 |
Pathological grading of regression: an International Study Group perspective R Chetty, P Gill, AC Bateman, DK Driman, D Govender, AR Bateman, ... Journal of clinical pathology 65 (10), 865-866, 2012 | 21 | 2012 |
National Working Group Meeting on ALK diagnostics in lung cancer W Cooper, S Fox, S O'toole, A Morey, G Frances, N Pavlakis, K O'byrne, ... Asia‐Pacific Journal of Clinical Oncology 10 (S2), 11-17, 2014 | 17 | 2014 |
Immunohistochemical expression of EGFR in colorectal carcinoma correlates with high but not low level gene amplification, as demonstrated by CISH C Hemmings, A Broomfield, E Bean, M Whitehead, D Yip Pathology 41 (4), 356-360, 2009 | 17 | 2009 |
Expression of PD‑L1 and SOX2 during rectal tumourigenesis: Potential mechanisms for immune escape and tumour cell invasion TJ Miller, MJ Mccoy, C Hemmings, B Iacopetta, CF Platell Oncology letters 16 (5), 5761-5768, 2018 | 16 | 2018 |
Menetrier's disease in a patient with ulcerative colitis: a case report and review of the literature CT Hemmings Pathology 39 (2), 282-283, 2007 | 16 | 2007 |
The changing face of GIST: implications for pathologists C Hemmings, D Yip Pathology-Journal of the RCPA 46 (2), 141-148, 2014 | 15 | 2014 |
Changes in the pathology reporting of rectal cancer: is it time to adopt synoptic reporting? C Hemmings, M Jeffery, F Frizelle The New Zealand Medical Journal (Online) 116 (1178), 2003 | 15 | 2003 |
Neuromuscular and vascular hamartoma arising in a Meckel's diverticulum CT Hemmings Pathology 38 (2), 173-174, 2006 | 14 | 2006 |
Primary omental synovial sarcoma: a case with cytogenetic confirmation C Hemmings, C Fisher Pathology 36 (2), 208-211, 2004 | 14 | 2004 |